|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.670 USD | -.--% |
|
-.--% | - |
| 07/10/25 | MannKind Corporation completed the acquisition of scPharmaceuticals Inc.. | CI |
| 07/10/25 | MannKind Completes Acquisition of scPharmaceuticals | MT |
| Market Cap | 305M 267M 246M 227M 431M 29.07B 438M 2.94B 1.15B 14.32B 1.14B 1.12B 49.24B | P/E 2027 * |
-
| P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 281M 246M 227M 209M 397M 26.79B 404M 2.71B 1.06B 13.2B 1.05B 1.03B 45.36B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
98.42% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: scPharmaceuticals Inc.
| 1 year | 4.13 |  | 6.28 |
| 3 years | 1.94 | | 8.98 |
| 5 years | 1.94 | | 12.75 |
| 10 years | 1.94 | | 18.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Castagna
CEO | Chief Executive Officer | 49 | 06/10/2025 |
| Director of Finance/CFO | 50 | 06/10/2025 | |
David Thomson
SEC | Corporate Secretary | 59 | 06/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Castagna
BRD | Director/Board Member | 49 | 06/10/2025 |
David Thomson
BRD | Director/Board Member | 59 | 06/10/2025 |
| Director/Board Member | 50 | 06/10/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/10/25 | Issuer sale | Director | 72,174 | 0.1442% | ||
| 06/10/25 | Issuer sale | Director | 84,422 | 0.1687% | ||
| 06/10/25 | Issuer sale | Director | 66,050 | 0.1320% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | +26.85% | -37.07% | 305M | |
| -2.33% | -2.09% | +50.33% | +162.29% | 1,085B | |
| -0.82% | -2.30% | +62.97% | +61.11% | 624B | |
| -0.73% | -4.98% | +27.22% | +84.46% | 442B | |
| +0.33% | -1.17% | +27.98% | +26.90% | 332B | |
| -0.02% | -2.85% | +25.27% | +44.88% | 282B | |
| -3.89% | -11.22% | +20.78% | +26.07% | 277B | |
| +0.66% | -1.42% | -29.26% | -39.30% | 217B | |
| -0.06% | -2.88% | +20.98% | +61.70% | 196B | |
| -3.72% | -1.10% | +13.35% | +71.53% | 167B | |
| Average | -0.80% | -2.92% | +24.65% | +46.26% | 362.22B | |
| Weighted average by Cap. | -0.58% | -2.97% | +35.36% | +81.69% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
163
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SCPH Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
